Toronto-based Blair Health has raised CAD $4.24 million in pre-seed financing in its first institutional funding round. The round was co-led by BDC’s Thrive Venture Fund, Accelia Capital and Ogaei, with participation from the Ontario Centre of Innovation through its Life Sciences Innovation Fund and angel investors. The financing brings Blair Health’s total capital raised to CAD $4.5 million.
Founded in December 2024 by CEO Madge Rumman and Chief Medical Officer Dr. Lindsay Shirreff, Blair Health develops clinical infrastructure designed to help generalist healthcare providers deliver care using specialist-designed clinical pathways.
The company’s software incorporates specialist-designed assessments, treatment protocols, clinical pathways and escalation rules. Its services currently cover areas including menopause and perimenopause, urology and pelvic health, and clinical nutrition and weight management.
Blair Health said the new capital will support engineering and product development, expansion of its commercial presence in Canada and the US, and investment in its clinical operations, provider network, team and supporting infrastructure. The company also plans to expand its employer channel and work with public-sector health systems in Canada.
The company launched its direct-to-consumer offering in May 2025 and said more than 2,300 women had signed up by the time of the funding announcement.
